REQUEST A DEMO
Total
USD $0.00
Search more companies

Representaciones Medicas Innovamedikal S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Representaciones Medicas Innovamedikal S.A. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Representaciones Medicas Innovamedikal S.A. is a company based in Ecuador, with its head office in Guayaquil. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on June 24, 2022. The total number of employees is currently 20 (2024). The company’s latest financial report indicates a net sales revenue drop of 13.32% in 2024. Over the same period, its total assets decreased by 11.29%. The enterprise’s net profit margin decreased by 37.72% in 2024.

Headquarters
Av. Fco de Orellana
Guayaquil; Guayas;

Contact Details: Purchase the Representaciones Medicas Innovamedikal S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Representaciones Medicas Innovamedikal S.A. report to view the information.
Registered Capital:
Purchase the Representaciones Medicas Innovamedikal S.A. report to view the information.
Financial Auditors:
Purchase the Representaciones Medicas Innovamedikal S.A. report to view the information.
Incorporation Date:
June 24, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Representaciones Medicas Innovamedikal S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.32%
Total operating revenue
-13.32%
Operating profit (EBIT)
-93.27%
EBITDA
-90.08%
Net Profit (Loss) for the Period
-98.07%
Total Assets
-11.29%
Total Equity
-28.12%
Operating Profit Margin (ROS)
-47.47%
Net Profit Margin
-37.72%
Return on Equity (ROE)
-82.31%
Debt/Equity
-0.02%
Quick Ratio
-1.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?